Historical salary details - Dr. Gwenn Hansen, PhD, Chief Scientific Officer, Nurix Therapeutics Inc
Dr. Gwenn Hansen, PhD has been the Chief Scientific Officer of Nurix Therapeutics Inc since 02 Apr 2018 and his latest salary was 2.0 M. View his historical salary.
Dr. Gwenn Hansen, Phd
Chief Scientific Officer
$ 2.0 M
Gross Remuneration
-
Current Company
Nurix Therapeutics Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Nurix Therapeutics Inc | Chief Scientific Officer | 2.0 M | -46.8 % |
| 2022 | Nurix Therapeutics Inc | Chief Scientific Officer | 3.8 M | 66.0 % |
| 2021 | Nurix Therapeutics Inc | - | 2.3 M | 48.4 % |
| 2021 | Nurix Therapeutics Inc | Chief Scientific Officer | 2.3 M | 48.4 % |
| 2020 | Nurix Therapeutics Inc | - | 1.6 M | 123.3 % |
| 2020 | Nurix Therapeutics Inc | - | 1.6 M | 123.3 % |
| 2020 | Nurix Therapeutics Inc | Chief Scientific Officer | 1.6 M | 123.3 % |
| 2019 | Nurix Therapeutics Inc | Chief Scientific Officer | 695.5 K | - |
| 2019 | Nurix Therapeutics Inc | - | 695.4 K | - |
| 2019 | Nurix Therapeutics Inc | - | 695.4 K | - |